Magenta Medical, based in Israel, develops self-expanding percutaneous mechanical circulatory support systems for heart patients.
Founded in 2012 in Israel, Magenta Medical Ltd. develops self-expanding percutaneous mechanical circulatory support systems intended to support cardiac function in patients with severe heart conditions. Its customers are hospitals and cardiac care centers, mainly in North America and Europe. The company has completed 6 deals and raised USD 105.00 mn in total, with the most recent round in July 2024 led by Novo Holdings. It is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in